142 related articles for article (PubMed ID: 37526458)
1. Therapeutic Potential of Plant Metabolites in Bone Apoptosis: A Review.
Devi K; Shanmugarajan TS
Curr Drug Targets; 2023; 24(11):857-869. PubMed ID: 37526458
[TBL] [Abstract][Full Text] [Related]
2. Osteocyte-Mediated Translation of Mechanical Stimuli to Cellular Signaling and Its Role in Bone and Non-bone-Related Clinical Complications.
Yan Y; Wang L; Ge L; Pathak JL
Curr Osteoporos Rep; 2020 Feb; 18(1):67-80. PubMed ID: 31953640
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase-dependent activation of latent transforming growth factor-beta controls the conversion of osteoblasts into osteocytes by blocking osteoblast apoptosis.
Karsdal MA; Larsen L; Engsig MT; Lou H; Ferreras M; Lochter A; Delaissé JM; Foged NT
J Biol Chem; 2002 Nov; 277(46):44061-7. PubMed ID: 12226090
[TBL] [Abstract][Full Text] [Related]
4. Pro-inflammatory Cytokines: Cellular and Molecular Drug Targets for Glucocorticoid-induced-osteoporosis via Osteocyte.
Wang T; Yu X; He C
Curr Drug Targets; 2019; 20(1):1-15. PubMed ID: 29618305
[TBL] [Abstract][Full Text] [Related]
5. Novel actions of bisphosphonates in bone: preservation of osteoblast and osteocyte viability.
Bellido T; Plotkin LI
Bone; 2011 Jul; 49(1):50-5. PubMed ID: 20727997
[TBL] [Abstract][Full Text] [Related]
6. The Role of Osteocytes in Age-Related Bone Loss.
Jilka RL; O'Brien CA
Curr Osteoporos Rep; 2016 Feb; 14(1):16-25. PubMed ID: 26909563
[TBL] [Abstract][Full Text] [Related]
7. Osteocyte network; a negative regulatory system for bone mass augmented by the induction of Rankl in osteoblasts and Sost in osteocytes at unloading.
Moriishi T; Fukuyama R; Ito M; Miyazaki T; Maeno T; Kawai Y; Komori H; Komori T
PLoS One; 2012; 7(6):e40143. PubMed ID: 22768243
[TBL] [Abstract][Full Text] [Related]
8. Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells.
Xiao G; Gopalakrishnan R; Jiang D; Reith E; Benson MD; Franceschi RT
J Bone Miner Res; 2002 Jan; 17(1):101-10. PubMed ID: 11771655
[TBL] [Abstract][Full Text] [Related]
9. Bone morphogenetic protein regulation of early osteoblast genes in human marrow stromal cells is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase signaling.
Osyczka AM; Leboy PS
Endocrinology; 2005 Aug; 146(8):3428-37. PubMed ID: 15905316
[TBL] [Abstract][Full Text] [Related]
10. Osteocyte-Related Cytokines Regulate Osteoclast Formation and Bone Resorption.
Kitaura H; Marahleh A; Ohori F; Noguchi T; Shen WR; Qi J; Nara Y; Pramusita A; Kinjo R; Mizoguchi I
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708317
[TBL] [Abstract][Full Text] [Related]
11. Bone morphogenetic protein-2 promotes osteoblast apoptosis through a Smad-independent, protein kinase C-dependent signaling pathway.
Haÿ E; Lemonnier J; Fromigué O; Marie PJ
J Biol Chem; 2001 Aug; 276(31):29028-36. PubMed ID: 11395480
[TBL] [Abstract][Full Text] [Related]
12. Pro-inflammatory cytokines TNF-related weak inducer of apoptosis (TWEAK) and TNFalpha induce the mitogen-activated protein kinase (MAPK)-dependent expression of sclerostin in human osteoblasts.
Vincent C; Findlay DM; Welldon KJ; Wijenayaka AR; Zheng TS; Haynes DR; Fazzalari NL; Evdokiou A; Atkins GJ
J Bone Miner Res; 2009 Aug; 24(8):1434-49. PubMed ID: 19292615
[TBL] [Abstract][Full Text] [Related]
13. Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway.
Wijenayaka AR; Kogawa M; Lim HP; Bonewald LF; Findlay DM; Atkins GJ
PLoS One; 2011; 6(10):e25900. PubMed ID: 21991382
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of Bcl2 in osteoblasts inhibits osteoblast differentiation and induces osteocyte apoptosis.
Moriishi T; Maruyama Z; Fukuyama R; Ito M; Miyazaki T; Kitaura H; Ohnishi H; Furuichi T; Kawai Y; Masuyama R; Komori H; Takada K; Kawaguchi H; Komori T
PLoS One; 2011; 6(11):e27487. PubMed ID: 22114675
[TBL] [Abstract][Full Text] [Related]
15. Smad4 controls bone homeostasis through regulation of osteoblast/osteocyte viability.
Moon YJ; Yun CY; Choi H; Ka SO; Kim JR; Park BH; Cho ES
Exp Mol Med; 2016 Sep; 48(9):e256. PubMed ID: 27585718
[TBL] [Abstract][Full Text] [Related]
16. A novel ligand-independent function of the estrogen receptor is essential for osteocyte and osteoblast mechanotransduction.
Aguirre JI; Plotkin LI; Gortazar AR; Millan MM; O'Brien CA; Manolagas SC; Bellido T
J Biol Chem; 2007 Aug; 282(35):25501-8. PubMed ID: 17609204
[TBL] [Abstract][Full Text] [Related]
17. Modulation of sclerostin expression by mechanical loading and bone morphogenetic proteins in osteogenic cells.
Papanicolaou SE; Phipps RJ; Fyhrie DP; Genetos DC
Biorheology; 2009; 46(5):389-99. PubMed ID: 19940355
[TBL] [Abstract][Full Text] [Related]
18. Constitutive protein kinase A activity in osteocytes and late osteoblasts produces an anabolic effect on bone.
Kao RS; Abbott MJ; Louie A; O'Carroll D; Lu W; Nissenson R
Bone; 2013 Aug; 55(2):277-87. PubMed ID: 23583750
[TBL] [Abstract][Full Text] [Related]
19. Activation of mitogen-activated protein kinase cascades is involved in regulation of bone morphogenetic protein-2-induced osteoblast differentiation in pluripotent C2C12 cells.
Gallea S; Lallemand F; Atfi A; Rawadi G; Ramez V; Spinella-Jaegle S; Kawai S; Faucheu C; Huet L; Baron R; Roman-Roman S
Bone; 2001 May; 28(5):491-8. PubMed ID: 11344048
[TBL] [Abstract][Full Text] [Related]
20. Bone morphogenetic protein receptors and bone morphogenetic protein signaling are controlled by tumor necrosis factor-alpha in human bone cells.
Singhatanadgit W; Salih V; Olsen I
Int J Biochem Cell Biol; 2006; 38(10):1794-807. PubMed ID: 16797218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
